Navigation Links
Study projects 60 percent increase in ESRD population by 2020
Date:11/3/2007

Although estimates have been adjusted downward in light of the most recent data, researchers still predict sharp increases in the U.S. incidence and prevalence of end-stage renal disease (ESRD) in the years ahead, according to a paper being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.

"The expected number of patients with ESRD in 2020 is almost 785,000, which is an increase of over 60 percent compared to 2005," comments Dr. David T. Gilbertson of the U.S. Renal Data System (USRDS) and the Minneapolis Medical Research Foundation, Minneapolis, Minn. Using data available through 2005, the study updates previous estimates based on data through 2000.

The researchers used statistical techniques to project available data on the ESRD population to the year 2020. The model took into account a wide range of factors, including expected trends in population growth and the rising rate of diabetesthe main cause of kidney disease. The study also incorporated the latest data on the risk of progression to ESRD once kidney disease is present.

Based on the results, Dr. Gilbertson and colleagues predict that the U.S. incidence (number of new cases) of ESRD will be about 135,000 in 2015. This figure is about 3,000 lower than the previous estimate. For reasons that are not entirely clear, the incidence of ESRD has been decreasing in recent years, and the updated figure accounts for that trend. The predicted prevalence (total number of cases) of ESRD in 2015 is estimated at 680,000about 33,000 less than the previous estimate.

Nevertheless, based on a combination of trendsincluding the aging of the "Baby Boomer" population, rising diabetes rates, and improvements kidney disease treatment allowing better survivalthe authors project continued increases in numbers of Americans affected by ESRD. By 2020, the incidence (new cases) of ESRD is expected to rise to 151,000 per year
'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
202-558-8423
American Society of Nephrology
Source:Eurekalert

3

GOOD

Page: 1 2

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... What: Cuts for a Cause ,, ... cancer and other terminal illnesses affecting children. All proceeds from ... Children,s Research Hospital. Guests will enjoy complimentary beverages and hors ... restaurant in Falls Church for all guests. Hoa Lai, a ...
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (HealthDay News) -- ... can have bad reactions to certain holiday traditions and ... wheezing, according to the American College of Allergy, Asthma ... live evergreens may choose to decorate with artificial plants, ...
(Date:12/5/2009)... by the National Association of Certified Professional Midwives ... for Midwifery (CfM), International Center for Traditional Childbearing ... the Midwifery Education Accreditation Council (MEAC). To ... Campaign to secure federal recognition of CPMs language ...
(Date:12/4/2009)... YORK, Dec. 4 Thousands of KPMG LLP employees came ... in a community service event which combines the audit, tax ... ,, "This national service day reflects our firm,s long history ... the spirit of caring to brighten the holidays for some ...
(Date:12/4/2009)... SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, ... announced the execution of a purchase and sale agreement ... in San Angelo, Texas, Corsicana, Texas, and Fort Wayne, ... acquisition is subject to the satisfaction of a number ...
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2
... offset the effect, study suggests , , TUESDAY, Dec. 30 ... be a major mechanism contributing to normal, age-related cognitive ... to change: rising blood glucose levels, which means that ... the December issue of Annals of Neurology ...
... ) announces the following Webcast: , , What: ... January 6, 2009 @ 11:00 EST, Where: http://www.videonewswire.com/event.asp?id=53900 , ... log on to the web at the address, ... Maynard of Neogen Corporation, +1-800-234-5333., , If you are ...
... LONDON, December 30 , - ... Give Your Child,GBP15,500 on Their 18th Birthday , ... http://www.thechildrensmutual.co.uk ) is encouraging all parents who decide,to give up ... that they will save towards their children,s futures. , ...
... The National Committee for Quality,Assurance and the American ... Terry Spears Barnett, M.D., Mirela Sturzu,M.D., Rudolf Teschan, ... Diabetes Physician Recognition Program for providing quality care ... Drs. Hany and Zaki practice at the Aurora ...
... 29 Curious about your child,s diet,preventing injury, ... daughter has a sports-related,injury? , ... sports coaches, parents and,athletes focused on education, communication ... (PEAKOrthopedics.com) to answer these questions,through an online, sports ...
... and Blue Shield of Oklahoma announced today the addition ... next policy year. This change will not in any ... been available to children with autism. Blue Cross and ... in the benefits and coverage of certain autism-related medically ...
Other Medicine News:Health News:Rising Blood Sugar May Harm the Aging Brain 2Health News:Rising Blood Sugar May Harm the Aging Brain 3Health News:Urging New Year Quitters to Invest in Their Family's Futures 2Health News:Aurora Physicians Receive National Recognition for Quality Diabetes Care 2Health News:SportZu.tv Partners With PEAK Orthopedics & Spine to Launch an Online Sports Doctor's Office 2Health News:Blue Cross and Blue Shield of Oklahoma Announces Autism Benefits 2
(Date:12/4/2009)... Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ... and chemical threats, announced today the presentation of new ... its lyophilized recombinant Protective Antigen (rPA) based anthrax vaccine ... various temperatures up to and including 55 degrees C. ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 1Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 2Senate Finance Committee Cuts Home Medical Equipment in Reform Package 57435 1Senate Finance Committee Cuts Home Medical Equipment in Reform Package 57435 2Aethlon Medical Inc Announces Annual Meeting Results 14111 1Aethlon Medical Inc Announces Annual Meeting Results 14111 2Aethlon Medical Inc Announces Annual Meeting Results 14111 3
... Achieved at Least 75 Percent Improvement in Psoriasis,Signs ... Five Dosing Groups, More,Than Half Achieved 90 Percent ... -- New,Phase II study results show Abbott's investigational ... patients treated. At 12 weeks, nine out of ...
... Studies Suggest FTY720 Mechanisms in Multiple,Sclerosis May Include ... studies suggest FTY720 stimulates cells,that may help reduce ... multiple sclerosis , · Separately, analyses from the ... the proportion of,patients with clinical depression was significantly ...
Other Medicine Technology:Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 3Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: